Silverarc Capital Management, LLC Erasca, Inc. Transaction History
Silverarc Capital Management, LLC
- $402 Million
- Q3 2024
A detailed history of Silverarc Capital Management, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 6,946,488 shares of ERAS stock, worth $22.4 Million. This represents 4.72% of its overall portfolio holdings.
Number of Shares
6,946,488
Previous 7,816,926
11.14%
Holding current value
$22.4 Million
Previous $18.4 Million
2.8%
% of portfolio
4.72%
Previous 5.23%
Shares
5 transactions
Others Institutions Holding ERAS
# of Institutions
141Shares Held
229MCall Options Held
28.7KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$62.6 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.8MShares$54.4 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$52.4 Million4.58% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$44.5 Million1.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$42.9 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $395M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...